Cases & Deals

OncoHoldings negotiates exclusive license for family of cancer compounds from TGen

Clients OncoHoldings, Inc.

Jones Day represented OncoHoldings, Inc. in connection with an exclusive license of a family of small molecule selective inhibitors of Histone Deacetylases (HDAC) by the non-profit Translational Genomics Research Institute (TGen).